# Quantitative Imaging Biomarker Prospective Validation of Dynamic Contrast-enhanced MRI as a Metric of Orodental Injury After Radiotherapy (QI-ProVE-MRI)

> **NCT06586892** · — · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 300 (estimated)

## Conditions studied

- Orodental Injury

## Interventions

- **BEHAVIORAL:** Radiotherapy followed by chemotherapy

## Key facts

- **NCT ID:** NCT06586892
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-15
- **Primary completion:** 2030-12-30
- **Final completion:** 2032-12-30
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-03-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06586892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06586892, "Quantitative Imaging Biomarker Prospective Validation of Dynamic Contrast-enhanced MRI as a Metric of Orodental Injury After Radiotherapy (QI-ProVE-MRI)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06586892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*